Characterization of very early circulating Natural Killer cells after hematopoietic stem cells transplantation
Authors:
- Alice Dahmer GonçalvesAGAlice Dahmer Gonçalves
- Raul Marques RodriguesRRRaul Marques Rodrigues
- Bruna Pochmann ZambonatoBZBruna Pochmann Zambonato
- Vanessa de Souza ValimVVVanessa de Souza Valim
- Filipe SehnFSFilipe Sehn
- Fabiane SpagnolFSFabiane Spagnol
- Annelise Martins Pezzi da SilvaASAnnelise Martins Pezzi da Silva
- Bruna AmorinBABruna Amorin
- Maria Aparecida Lima da SilvaMSMaria Aparecida Lima da Silva
- Aline Fatima PazAPAline Fatima Paz
- Alessandra Aparecida PazAPAlessandra Aparecida Paz
- Lucia Mariano da Rocha SillaLSLucia Mariano da Rocha Silla
Open Access
- 1 September 2025
- journal article
- research article
- Published by Brazilian Journals in Brazilian Journal of Health Review
- Vol. 8 (5) , e83022
Abstract
Natural Killer cells are the first lymphocyte subpopulation to reconstitute after hematopoietic stem cell transplantation. Peripheral blood samples from thirteen patients who underwent allogeneic and autologous hematopoietic stem cell transplantation were analyzed at days 7, 14, 21 and 28 (± 2) after transplantation. Peripheral blood mononuclear cells were isolated using the Bulk Lysis™ EuroFlow standard operating protocol. They were stained for membrane markers with anti-CD45, anti-CD56, anti-CD16, anti-CD3, anti-CD14, anti-CD19, anti-CD2 and anti-CD7; and for intracellular cytokine detection with anti-IL-3, anti-GM-CSF and anti-TGF-1β. On day 7, the presence of Natural Killer cells was detected in 9 patients (mean: 11.6%, SD±: 6.3 of lymphocytes) as well as on day 14 (mean: 16.3%, SD±: 8.2), day 21 (mean: 31.6%, SD±: 9.5) and day 28 (mean: 22.7%, SD±: 6.1). An increase in CD56+16+ phenotype recovery was observed at days 21 (mean: 22%, SD±: 7.2 of lymphocytes, range: 8.0 – 36.1) and 28 (mean: 16%, SD±: 4.9, range: 6.6 – 25.7) when it was compared with CD56bright and CD56+16- (p<0.05). The production of cytokines IL-3, GM-CSF and TGF-β1 was observed during the recovery period of Natural Killer cells within 28 days after transplantation (p=0.04). These data suggest that Natural Killer cells have the ability to produce hematopoietic growth factors and related cytokines which may contribute to the reestablishment of hematopoiesis after transplantation, prevent graft-versus-host disease and enhance the engraftment.Keywords
This publication has 23 references indexed in Scilit:
- TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathwayScience Signaling, 2016
- Natural killer cell biology: An update and future directionsJournal of Allergy and Clinical Immunology, 2013
- TGF‐β affects development and differentiation of human natural killer cell subsetsEuropean Journal of Immunology, 2010
- Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemiaLeukemia, 2007
- Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donorsBone Marrow Transplantation, 2003
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- NK cells recover early and mediate cytotoxicity via perforin/granzyme and Fas/FasL pathways in umbilical cord blood recipientsHuman Immunology, 2001
- Analysis of immune reconstitution in children undergoing cord blood transplantationExperimental Hematology, 2001
- Immune reconstitution following allogeneic peripheral blood stem cell transplantsBone Marrow Transplantation, 1999
- Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.Journal of Clinical Investigation, 1998